Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16921033 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
Conditions: Carcinoma, Small Cell;   Lung Neoplasms
Interventions: Radiation: hypofractionated concurrent chemoradiotherapy;   Radiation: conventionally fractionated concurrent chemoradiotherapy
2 Completed Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Radiation: radiation therapy

Indicates status has not been verified in more than two years